comprehensive -WSS

comprehensive

author：focus 2025-09-27 23:33:17 - browse：7174

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The battle over the Brookhaven Landfill on Long Island

WSS

What would happen to your eyes if you looked at the solar eclipse?

Flagship Pioneering startup Sonata Therapeutics lays off 21

WATCH: Why do fingernails fall off when they're damaged?

With FDA staff opposed to Sarepta therapy, top official intervened

CDC concerned about possible undetected monkeypox spread in U.K.

Paxlovid study fails to answer questions over benefit for broader groups

focus

comprehensive

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Researchers tackle phage therapy hurdles for wider adoption

How to save PrEP access — and even expand it

Secretariat’s lessons for human medicine

Hepatitis C has a cure — but many Americans still lack access to it

Congress may force more Covid

Hepatitis C has a cure — but many Americans still lack access to it

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Novavax promises a turnaround & Lilly roils the obesity market

Donald Trump's relentless attacks on special counsel Jack Smith

knowledge

Do masks work? RCTs can't tell us

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

WATCH: Why do fingernails fall off when they're damaged?

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

STAT's guide to the next generation of CAR

New guidelines on severe brain injury complicate already difficult decisions

focus

Wikipedia

focus

explore